There are two possible mechanisms toexplain the initial improvement of hepatitis in our case: the PPARγ ligand may have directly suppressed theabnormal cell growth, or the PPARγ ligand may have indirectly suppressed tumor growth after the ligandimproved hepatitis and/or diabetes. The gene discussed is PPARG; the disease is diabetes mellitus.